A novel electroporation approach was designed for PB transposon to generate GPC3-specific CAR-T cells for HCC therapy. These cells able to reduce tumour while simultaneously secreting high level of interferon-γ. Findings suggest that PB system based GPC3-CAR-T cells may be a promising strategy for HCC patients. This evidence concerns the gene GPC3 and neoplasm.